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Role of nitric oxide in the effect 
flow on neointima formation 
of blood 
Martin I. Ellenby, MD, Calvin B. Ernst, MD, Oscar A. Carretero, MD, and 
A. Guillermo Scicli, PhD, Detroit, Mich. 
Purpose: Neointima formation after arterial injury is inhibited by increased blood flow. The 
object of  this study was to determine whether nitric oxide mediates the effect of  increased 
blood flow on neointima formation. 
Method: Balloon catheter-denuded rat carotid arteries were exposed to increased blood 
flow or control blood flow by ligation of  the contralateral carotid artery. Beginning 2 days 
before balloon denudation, rats were given either saline vehicle alone or the nitric oxide 
synthase inhibitor N-nitro-L-arginine-methyl ester (L-NAME) at a dose of  10 mg/kg/day 
or 2 mg/kg/day intraperitoneally. The normalized neointima area was measured 14 days 
after denudation. 
Results: Blood flow was significantly increased by ligation of the contralateral carotid artery 
for all drug treatments (p < 0.008). In rats given saline vehicle only, normalized 
neointima rea was significantly reduced after increased blood flow compared with control 
blood flow (0.33 + 0.04 compared with 0.48 + 0.03;p --- 0.006). Systolic blood pressure 
was significantly elevated by treatment with high-dose L-NAME (p = 0.002 compared 
with vehicle), but was not altered by low-dose L-NAME (p = NS compared with vehicle). 
Normalized neointima rea was not significantly reduced after increased carotid blood 
flow for rats treated with either dose of L-NAME (p = NS). 
Conclusion: The inhibition of neointima formation by increased blood flow was abolished 
with hypertensive and nonhypertensive doses of the nitric oxide synthase inhibitor 
L-NAME, which suggests that the L-NAME effects are independent of systemic 
hemodynamic alterations. It is concluded that flow-induced inhibition of neointima 
formation is mediated in part by nitric oxide. (J VASC SURG 1996;23:314-22.) 
The formation of a hyperplastic neointima is a 
major cause for restenosis n the first year after arterial 
reconstruction or balloon angioplasty) -a The results 
of these procedures to correct arterial insufficiency are 
dependent on the extent of the restenosis caused by 
neointimal hyperplasia. 24 A better understanding of 
the stimuli and inhibitors of neointima formation 
may lead to improved techniques of arterial recon- 
struction. 
Clinical and experimental observations suggest 
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that a variety of hemodynamic factors, such as blood 
flow, shear stresses, pressure, pulsatility, and vascular 
deformation, affect neointima formation within ar- 
terial bypass grafts or at sites of arterial repair, sn  In 
some studies, the magnitude of neointima formation 
in an arterial graft or near a surgical anastomosis was 
reported to be inversely related to the magnitude of 
local wall shear stress, -za2a3 The mechanisms 
whereby increased blood flow or shear stress alters 
neointima formation are not clear. 
Blood flow-induced shear stress is perhaps the 
most potent stimulus for the production of nitric 
oxide (NO) by vascular endothelium.14-~8 In experi- 
mental models, NO has an antiproliferative effect on 
vascular smooth muscle cells (VSMCs). 19-22 Some 
reports have suggested that NO also inhibits migra- 
tion of VSMCs. 22 Furthermore, NO inhibits platelet 
aggregation and leukocyte adhesion. 2325 
The effect of elevated blood flow on neointima 
formation has not been linked to flow-dependent 
alterations in NO. The goal of this study was to 
determine whether NO mediates the inhibition of 
neointima formation by increasing blood flow. 
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MATERIAL AND METHODS 
General protocol. A balloon-catheter denuda- 
tion model of arterial injury was used to induce 
neointima formation in the left common carotid 
artery (CCA) of male Sprague-Dawley rats weighing 
350 g to 450 g (Charles River Laboratories, Portage, 
Mich.). Denuded left CCAs were subjected to 
conditions of unaltered blood flow (control) or 
increased blood flow by ligating the right CCAs and 
external carotid arteries (ECAs) immediately after 
denudation. To elucidate the role of NO, randomly 
selected subsets of animals were treated with the NO 
synthase inhibitor N-nitro-L-arginine-methyl ester 
(L-NAME; Sigma Chemical Co., St. Louis). Rats 
were continuously treated with either saline (vehicle), 
intraperitoneal L-NAME at 10 mg/kg/day, or intra- 
peritoneal L-NAME at 2 mg/kg/day beginning 2 
days before CCA denudation. CCA blood flow was 
measured in anesthetized rats immediately before 
denudation and after 14 days. Blood pressure was 
measured in anesthetized rats on the day of denuda- 
tion (day 0) and on day 14. Blood pressure also was 
measured at 4- to 5-day intervals in awake rats. 
Fourteen days after denudation the rats were killed, 
and the CCAs were harvested for morphometric 
analysis of the neointima. 
The rats were divided into six groups on the basis 
of treatment of the right CCA (patent or ligated) and 
drug treatment (saline vehicle, high-dose L-NAME, 
or low-dose L-NAME; Table I). The care of all 
animals complied with the "Principles of Laboratory 
Animal Care" (formulated by the National Society 
for Medical Research) and the Guide for the Care and 
Use of Laboratory Animals (NIH Publication No. 
86-23, revised 1985). This experimental protocol 
also was approved and monitored by the Care of 
Experimental Animals Committee of the Henry Ford 
Hospital. 
Drug dose selection and administration. 
L-NAME was administered torats in groups III, IV, 
V, and VI. Groups I and II were given saline vehicle 
alone. L-NAME was dissolved in saline vehicle for 
delivery through an intraperitoneal osmotic pump 
(Alzet 2ML2; Alza Corp; Palo Alto, Calif.). With 
each rat under ether anesthesia, the osmotic pump 
was implanted into the peritoneal cavity 2 days before 
arterial injury. High-dose L-NAME, 10 mg/kg/day, 
was administered to groups III and IV. Groups V 
and VI were given low-dose L-NAME, 2 mg/kg/day. 
In previous tudies in this laboratory, a similar low 
dose of L-NAME (1.44 mg/kg/day) did not alter 
blood pressure. 26 
Arterial injury model. The endothelium of the 
left CCA was denuded with balloon catheters that 
were constructed by securing a 15-mm segment of 
silicone rubber tubing to the end of fine polyethylene 
tubing with cyanoacrylate. The end of the tube was 
sealed with silicone gel. The balloon was distended 
with saline to a maximum diameter of approximately 
2.5 mm. The size of the balloon was controlled by the 
use of a 0.5-ml syringe connected to the catheter by 
a stopcock. 
Rats were anesthetized with sodium pentobar- 
bital (50 mg/kg by intraperitoneal injection). After 
insertion of a femoral artery catheter for measure- 
ment of blood pressure, the left CCA was exposed 
with minimal manipulation with a midline neck 
incision. The external diameter of the CCA was 
measured with an operating microscope fitted with a 
graded objective lens. After measuring the baseline 
blood flow in the CCA, the balloon catheter was 
introduced into the CCA through an arteriotomy in
the ECA and advanced into the aorta. The balloon 
was distended to 120% of the diameter of the CCA 
with a predetermined volume of saline. This tech- 
nique controls for variability in artery size, standard- 
izing the depth of injury to the intima and media. The 
distended balloon was withdrawn through the CCA 
three times. The balloon catheter was removed, and 
the ECA was ligated. Pilot studies confirmed effective 
denudation of the CCA endothelium with this 
technique and the formation of a thickened neoin- 
tima by 14 days. 
All rats underwent exposure and circumferential 
dissection of the right CCA and ECA. After denu- 
dation of the left CCA, the right CCA and ECA were 
ligated in groups II, IV, and VI. Rats in the other 
groups underwent a sham dissection of the right 
CCA and ECA without ligation (Table I). 
Alteration of blood flow and blood flow 
measurements. Blood flow in the left CCA was 
increased by ligation of the right CCA and ECA. 
Pilot studies documcnted a 50% to 100% increase in 
left CCA blood flow within 5 minutes of right CCA 
and ECA ligafion in most rats and a sustained 
increase in left CCA blood flow over 14 days. Blood 
flow was measured in anesthetized rats with a 
flowmeter (T206 Small Animal Flowmeter, Tran- 
sonic Systems Inc., Ithaca, N.Y.) with a perivascular 
probe (Transonic RR2) placed around the left CCA. 
The system provides adirect measurement of volume 
flow (resolution = 0.05 ml/min, relative accu- 
racy = + 2%).  27 The CCA was minimally manipu- 
lated to avoid inducing vasospasm. The mean blood 
flow was recorded on a strip-chart recorder through- 
out a 10-minute interval after allowing for stabiliza- 
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Table I. Description of experimental groups 
L-NAME dose Carotid outer diameter 
Group RCL (mg/kg/day) n Weight (tim) (mm) 
I No 0 9 374 _+ 10 1.05 ± .05 
II Yes 0 10 382 _+ 9 1.05 _+ .04 
II I  No 10 6 388 _+ 12 1.02 _+ .05 
IV Yes 10 7 384 _+ 11 1.05 -+ .05 
V No 2 10 393 _+ 9 1.09 -+ .04 
VI Yes 2 11 379 -+ 9 1.11 _+ .04 
Values are expressed as mean -- SEM. 
RCL, right carotid ligation. 
tion of the flow after probe placement. A dose-related 
diminution of cerebral blood flow caused by the 
administration of sodium pentobarbital was ex- 
pected, 28 and does not invalidate a comparison of 
relative changes in CCA blood flow because the 
dosing of the sodium pentobarbital was stan- 
dardized. 
Blood pressure measurement. Systolic blood 
pressures were measured with a catheter placed into 
the abdominal orta through the left femoral artery. 
The catheter was inserted in anesthetized rats before 
CCA exposure. The catheters were tunneled subcu- 
taneously and exited through the nape of the neck. 
Blood pressure was measured with a pressure trans- 
ducer (P-50, Viggo-Spec~amed, Oxnard, Calif.) and 
printed on a strip-chart ecorder. Blood pressure was 
measured in anesthetized rats concurrent with CCA 
blood flow measurements on day 0 and day 14. Blood 
pressure also was measured in awake restrained rats 
on three occasions at 4- to 5-day intervals throughout 
the 14 days after CCA intimal denudation. 
Measuring neointima formation. Fourteen days 
after CCA intimal denudation, rats were anesthetized 
with sodium pentobarbital (50 mg/kg intraperitone- 
al), and the left CCA was exposed. After measuring 
blood pressure and CCA blood flow, a perfusion 
cannula was placed through the left ventricle into the 
ascending aorta. The right atrium was incised for 
drainage. The rats were exsanguinated and flushed 
with phosphate-buffered saline (approximately 150 
ml) until the washout was clear. The vascular system 
was then perfusion-fixed with 2.5% glutaraldehyde 
(approximately 250 ml) delivered at a pressure of l00 
mm Hg with an infusion pump. The left CCA was 
excised, mounted on a styrofoam block to maintain 
its in-situ length, and submerged in 2.5% glutaral- 
dehyde for at least 24 hours. The central segment of 
each CCA, from 4 mm distal to the CCA origin to 
4 mm proximal to the CCA bifurcation, was excised 
and embedded in paraffin. This central segment of the 
CCA was chosen because it was removed from the 
effects of turbulent flow near the origin and bifurca- 
tion of the CCA. Concentric cross-sections of10-~m 
thickness were cut from the central CCA segment and 
stained with hematoxylin and eosin. 
Morphometric measurements of the area of the 
lumen, intima, media, and total artery were made by 
an examiner blinded to the treatment group for each 
specimen. The areas were measured from the his- 
tologic cross-sections with a microscope attached 
to a camera lucida (Leitz Wetzlar, Germany) and 
a Summa-sketch digitizer tablet (Summagraphics 
Corp., Seymour, Conn.) linked to a computer. The 
intima area was defined as the area within the internal 
elastic lamina minus the lumen area. The media area 
was defined as the area between the internal and 
external elastic laminae. The total artery wall area was 
defined as the entire area within external elastic 
lamina minus the lumen area. 
Statistical analysis. Rat weights and diameters 
of the left CCA were compared with two-way 
analysis of variance (ANOVA). Univariate repeated 
measures ANOVA was used to evaluate CCA blood 
flow and blood pressures. Within the repeated 
measures ANOVA model, L-NAME dose, CCA 
blood flow level, and time were analyzed with all 
of their interaction terms, A significant ime-by- 
blood-flow interaction effect was detected for CCA 
blood flow. Therefore, differences in blood flow at 
day 0 and day 14 were evaluated separately within 
each group with paired t tests with the Bonferroni 
multiple comparison adjustment (reduction of 
level to 0.0083). 
An estimate of mean shear stress in the left CCA 
on day 14 was calculated with the Hagen-Poiseuille 
formula, in which shear stress is directly related to the 
product of the kinetic viscosity of blood (0.035 
poise) and blood flow (ml/sec), divided by the cube 
of the arterial radius (cm3). Blood viscosity was 
assumed to be constant. The blood-flow volume on 
day 14 was measured directly, and the radius of the 
lumen was derived from the measured lumen area. 
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Two-way ANOVA was used to compare lumen area 
and the calculated shear stress. 
Neointima formation was normalized for vari- 
ability in arterial size by expressing neointima for- 
mation as the ratio ofintimal area to total arterial wall 
area (normalized neointima rea [NNA]). The ratio 
of intimal area to total wall area was chosen because 
it had a smaller coefficient of variation than the ratio 
of intimal area to medial area and because it did not 
have a strong correlation to animal weight or CCA 
diameter. Two-way ANOVA without repeated mea- 
sures was used to evaluate NNA. Within the two-way 
ANOVA model, L-NAME dose and CCA blood 
flow were analyzed along with their interaction 
terms. Because the drug-by-blood-flow interaction 
effect was almost statistically significant for the 
analysis of NNA, differences in the NNA between 
blood-flow levels within each L-NAME treatment 
were analyzed, with Student wo-sample t tests with 
the Bonferroni multiple comparison adjustment (re- 
duction in ~ level to 0.016). 
Power analysis indicates that the sample sizes of 
six and seven animals for the high-dose L-NAME 
treatment groups were adequate to detect a mean 
group difference in NNA equivalent to the difference 
observed for the animals receiving saline vehicle alone 
(mean NNA difference, 0.15; power, 0.8). 
RESULTS 
No differences in body weight or in the outer 
diameters of the left CCAs were found among the six 
groups (ANOVA, p = NS; Table I). Systolic blood 
pressures in anesthetized rats did not change from 
day 0 to day 14 for each group (repeated measures 
ANOVA, p = NS). Treatment with high-dose 
L-NAME, however, significantly elevated the systolic 
blood pressures measured in anesthetized rats com- 
pared with rats receiving saline vehicle alone or low- 
dose L-NAME (repeated measures ANOVA, p < 
0.001). Furthermore, systolic blood pressures in 
awake animals were significantly elevated after treat- 
ment in animals treated with high-dose L-NAME 
compared with those treated with saline vehicle alone 
or low-dose L-NAME (repeated measures ANOVA, 
p = 0.002). Treatment with low-dose L-NAME did 
not alter the systolic blood pressures compared with 
saline vehicle in awake or anesthetized animals (re- 
peated measures ANOVA, p = NS). Awake and 
anesthetized systolic blood pressures did not 
change over time for any group (repeated measures 
ANOVA, p = NS; Table II). 
Left CCA blood flow increased significantly from 
the day of CCA intimal denudation to day 14 for all 
groups undergoing ligation of the right CCA and 
ECA (paired t test with Bonferroni's adjustment, 
p < 0.008). Although CCA blood flow tended to 
increase in the groups without contralateral CCA 
ligation, the increase was not statistically significant 
(paired t test with Bonferroni's adjustment, p = NS; 
Fig. 1). For each drug treatment, rats with contralat- 
eral CCA ligation had increased left CCA flow on day 
14 compared with rats without (Student two-sample 
t test with Bonferroni's adjustment; p < 0.001 for 
vehicle, p = 0.001 for low-dose L-NAME, p = 
0.050 for high-dose L-NAME; Table III). 
The lumen areas did not differ significantly 
between groups (two-way ANOVA, p = NS). The 
calculated estimates of mean shear stress in the left 
CCA on day 14, however, were significantly greater 
for rats with contralateral CCA ligation compared 
with the rats without (two-way ANOVA, p - -  
0.0388; Table IV). 
The increased blood flow in rats receiving saline 
vehicle resulted in a 31% reduction in NNA (Student 
two-sample t test with Bonferroni's adjustment, 
p = 0.006). NNA was not significantly reduced in 
rats with right CCA ligation, however, when either 
high-dose L-NAME or low-dose L-NAME was 
given (groups IV and VI), despite increased CCA 
blood flow (by Student two-sample t test with 
Bonferroni's adjustment, p = NS; Table III). NNA 
was significantly less in the CCAs subjected to high 
blood flow but not treated with L-NAME (group II) 
in comparison with the CCAs subjected to high 
blood flow and L-NAME treatment (groups IV and 
VI; p = 0.011 by one-way ANOVA with Bonfer- 
roni's adjustment). Therefore, the inhibition of 
neointima formation induced by increased blood 
flow was abolished by treatment with both hyper- 
tensive and nonhypertensive doses of L-NAME. In 
addition, treatment with either dose of L-NAME did 
not significantly alter NNA for rats without blood- 
flow elevation (group I versus III and V; by one-way 
ANOVA with Bonferroni's adjustment, p = NS; 
Fig. 2). 
DISCUSSION 
As early as 1906, Carrel and Guthrie 29 observed 
thickening of veins grafted into arterial systems. 
Neointimal hyperplasia remains a major cause of 
early restenosis after reconstructive arterial surgery 
and balloon angioplasty. 1-3 Shear stress exerted by the 
flow of blood on the lumenal surface of blood vessels 
has been proposed to be an important modulator of 
neointima formation, sl° Shear stress is directly 
proportional to the rate of blood flow as described by 
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Fig. 1. Bar graphs howing left CCA blood flow on days 0 and 14. *, p < 0.008 by paired 
t tests with Bonferroni's adjustment for groups II, IV, VI on day 14 compared with day 0. 
Table II. Blood pressure measurements 
Anesthetized systolic Anesthetized systolic Awake systolic BP, 
L-NAME dose BP, day 0 BP, day 14 days 1-14 
Group RCL (mg/kg/day) (ram Hg) (ram Hg) (ram Hg)* 
I No 0 106 - 6 116 ± 5 151 ± 6 
II Yes 0 122 ± 6 116 + 5 144 _+ 4 
II I  No 10 154 ± 5t 156 ± 16t 174 ± 9t 
IV Yes 10 139 ± 6~ 142 ± 4~- 174 ± 8t 
V No 2 120 ± 3 120 + 6 145 + 6 
VI Yes 2 118 ± 8 106 _+ 9 145 + 3 
Values are expressed as mean _+ SEM. 
BP, blood pressure; RCL, right carotid ligation. 
*Means for three measurements made in awake rats over 4- to 5-day intervals from days 0 to 14. 
tp < 0.05 by repeated measures ANOVA for overall comparison of high-dose L-NAME to saline vehicle and low-dose L-NAME. 
the Hagcn-Poiseuille equation. It has been reported 
that the magnitude of neointima formation is in- 
versely related to the rate of blood flow in surgically 
manipulated arteries, vein grafts, and prosthetic 
arterial conduits. This observation has been made 
experimentally s,7-9 and clinically) t,12,a° The data of 
the present study are consistent with these observa- 
tions. It is not clear, however, whether this relation- 
ship is universal to all vascular systems. 
Which precise vector component of the shear 
stress is most responsible for alterations in neointima 
formation has been debated. 8,31,32 Nevertheless, com- 
pelling experimental evidence suggest that shear 
stress affects the rate of VSMC proliferation. 7,a3 In 
experimental nimal models of arterial reconstruc- 
tion, increased blood flow has been associated with 
decreased neointima formation in vein grafts, 18'3l'34 
in polytetrafluoroethylene grafts, 7'9,35 and in denuded 
arteries. 36 
The object of this study was to test he hypothesis 
that NO mediates the effect of blood flow on 
neointima formation. The formulation of this hy- 
pothesis was based on two premises: (1) Shear stress 
is a major stimulus for NO production from endo- 
thelial cells, 14-18 and (2) NO has antiproliferative 
effects on VSMCs.  19-22 In our study, neointima 
formation was significantly inhibited in denuded 
CCAs by increased blood flow. The inhibition of 
neointima formation induced by increased blood 
flow was abolished with both hypertensive and 
nonhypertensive doses of the NO synthase inhibitor 
L-NAME (Fig. 2). These results suggest hat the 
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Table I lL Carotid blood flow and NNA 
L-NAME dose Carotid blood flow, 
Group R CL (mg/kg/day) n day 14 (ml/min) NNA 
I No 0 9 6.56 + 0.33 0.48 .+ 0.03 
II Yes 0 10 10.73 _+ 0.81"t  0.33 _+ 0.045 
III No  10 6 5.40 _+ 0.67 0.54 + 0.02 
IV Yes 10 7 8.47 .+ 1.15"~- 0.46 _+ 0.05 
V No 2 10 6.26 .+ 0.55 0.45 _+ 0.04 
VI Yes 2 11 10.18 -+ 0.87** 0.47 -- 0.03 
Values are expressed as mean --+ SEM. 
RCL, right carotid ligation. 
NNA, normalized neointimal area. 
*p < 0.008 by paired t test with Bonferroni's adjustment, comparing days 0 and 14. 
tp < 0.008 by Student's two-sample t test with Bonferroni's adjustment for group II vs I, and group VI vs V; p = 0.05 for group IV 
vs III. 
Sp = 0.006 by Student's two-sample t test with Bonferroni's adjustment for group II vs I; p = 0.011 by one-way ANOVA with 
Bonferroni's adjustment for group II vs IV and VI. 
Table IV. Lumen area and calculated mean shear stress 
Calculated mean 
L-~L4_ME dose Lumen area shear stress 
Group R CL (mg/kg/day) n (ram 2) (dynes~era 2 )
I No  0 9 0.287 .+ 0.022 212 _+ 30 
II Yes 0 10 0.344 +_ 0.021 262 -- 32* 
III No 10 6 0.306 .+ 0.027 132 .+ 37 
IV Yes 10 7 0.320 .+ 0.025 193 _+ 34* 
V No 2 10 0.310 .+ 0.021 159 .+ 29 
VI Yes 2 11 0.346 .+ 0.020 214 _ 29* 
Values are expressed as mean _+ SEM. 
Mean shear stress calculated with Hagen-Poiseuille formula: ~ = 4~tQ/wr 3 where r is shear stress,/x is blood viscosity (0.035 poise), Q 
is blood flow (ml/sec), and r is the radius of  the artery (cm). Q is measured irectly; r is derived from measure of  lumen area. 
*p = 0.039 by two-way ANOVA comparing roups with contralateral carotid ligation to groups without contralateral carotid ligation. 
effects of increased blood flow on neointima forma- 
tion are mediated at least in part by NO because 
increased blood flow failed to influence neointima 
thickness when NO synthesis was blocked. NO has 
been implicated as an inhibitor of neointima for- 
mation after balloon injury. In two independent 
experiments, administration of the NO precursor 
L-arginine inhibited the migration and proliferation 
of medial VSMCs in rat CCAs after balloon in- 
jury. 21'22 The mechanisms by which L-arginine acts 
are not clear. Although endogenous L-arginine is 
abundant and not limiting, it has been proposed that 
NO mediates this response to exogenous L-arginine. 
Nitroglycerin, an NO donor, administered to rats 
undergoing catheter denudation of CCAs, decreased 
medial cellular proliferation but had no significant 
effect on intimal cellular proliferafon. 19 Chronic 
inhibition of NO by the administration of L-NAME 
did not increase the intima area 21,22 or  the 
intima/media rat io 22 in studies that used a rat CCA 
balloon-injury model. Treatment with L-NAME, 
however, significantly increased intimal area in rab- 
bits after arterial balloon injury, although no signif- 
icant change in the intima/media ratio was ob- 
served. 2° The apparent inconsistency in these reports 
might reflect a species-dependent response to 
L-NAME or NO. 
In our study, rats with unaltered CCA blood flow 
that were treated with L-NAME (groups III and V) 
did not have significantly increased NNA compared 
with rats receiving saline vehicle alone (group I). This 
suggests that basal NO levels play little role in the 
regulation of neointima formation under control 
conditions. Conversely, stimulation of NO forma- 
tion effectively imits neointima formation. Increases 
in NO elicited by either increased flow, as suggested 
by our study, treatment with angiotensin converting 
enzyme inhibitors, 26 treatment with a NO donor, ~9 
or NO synthase gene t ransfer  37 have reduced neoin- 
tima formation in experimental nimals. 
The source of the NO responsible for the effects 
of increased blood flow remains to be determined. 
NO synthase has three main forms: a constitutive 
calcium-dependent form present in endothelial 
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Fig. 2. Bar graphs howing NNA 14 days after balloon catheter denudation ofthe left CCA. 
,p = 0.006 by Student two-sample t test with Bonferonni's adjustment for group II compared 
with I; p = 0.011 by one-way ANOVA with Bonferroni's adjustment for group II compared 
with IV and VI. 
cells, 38,a9 a constitutive form found in neurons, 25 and 
an inducible calcium-independent form identified in 
VSMCs. 4° Joly et al.41 documented that balloon 
injury to the rat CCA induces the production of NO 
in the arterial wall. Increased levels of cyclic 3'5'- 
guanosine monophosphate, he second messenger 
for NO, has been found in injured arterial segments 
subjected to increased blood flow or after nitroglyc- 
erine administration. 19 Thus, evidence suggests that 
NO may be produced in the immediate vicinity 
of the injury. The data from the present study indicate 
that right CCA ligation increased both left CCA 
blood flow and calculated estimates of mean shear 
stress, and the effect of increased blood flow on 
neointima formation was abolished by treatment 
with L-NAME. Because only the constitutive form of 
NO synthase has been associated with changes in 
shear stress and increases in intracellular calcium and 
no data suggest participation ofneuron-derived NO, 
it is likely that adjacent endothelial cells are the source 
of the involved NO. 
If a systemic pool of NO derived from endothelial 
cells is responsible for the protective ffects of high 
blood flow, the blood flow-induced effects on 
neointima formation should be blocked only by a 
dose of L-NAME sufficient to suppress endothelial 
NO formation systemically, which would in turn 
cause hypertension. The present study suggests a
local source of NO, however, because the effect of 
increased blood flow on neointima formation was 
inhibited by a low-dose of L-NAME that did not alter 
systemic blood pressure. Endothelial cells neighbor- 
ing the injured artery may be stimulated by the higher 
blood flow to release NO, which may suppress 
neointima formation in the adjacent injured artery. 
For this hypothesis tobe plausible, NO released from 
adjacent endothelial cells in response to elevated 
blood flow would require transport to the site of 
injury by a carrier molecule because the distance 
between the proximal endothelialized part of the 
artery and the distal injured part is relatively great, 
and NO is known to be short-lived. 2sIt has been 
postulated that NO forms adducts with plasma 
proteins that serve as transporters. 42 This system 
would need to be sensitive to low-dose L-NAME to 
be involved in the blood flow-induced inhibition of 
neointima formation that was observed in this study. 
The transduction fblood flow or shear stress to 
NO production may be related to changes in 
intracellular calcium. The effect of changes in blood 
flow on cell surface endonucleotidases has been 
linked to changes in the mass transport of adenosine 
triphosphate and changes in intracellular Ca 2 + 43 NO 
production i  cultured endothelial cells is modulated 
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by adenosine triphosphate and intracellular Ca 2 +. 15,16 
Increased shear stress also appears to stimulate the 
release of NO by activating potassium channels in the 
endothelial cell membrane. 44,45 
CONCLUSION 
The data of this study support the findings of 
Kohler and Jawien, 36 who conducted similar experi- 
ments with balloon injury to rat CCAs subjected to 
various magnitudes of blood flow. By measuring 
thymidine flow indexes, they reported that VSMC 
proliferation did not differ for injured CCAs exposed 
to low or high blood flow levels. Their data suggest 
that the inhibition of neointima formation induced 
by increased blood flow might be a function of an 
alteration in VSMC migration. 
Although our data suggest hat the NO synthase 
involved may be the constitutive nzyme present in 
endothelial cells, the nature of the NO synthase 
(constitutive or inducible) involved in blood flow- 
induced changes in neointima formation and the 
responsible cell type (endothelial cells, VSMCs, 
platelets, or leukocytes) remain to be established. 
Although changes in VSMC migration have been 
implicated as the path by which NO alters neointima 
formation in response to blood flow, 36 the precise 
mechanisms of this interaction are not clear. The NO 
induced by increased blood flow may inhibit VSMC 
migrat ion  directly 22"36 or indirectly, perhaps by alter- 
ing local platelet activity. 23'24 Platelets synthesize and 
release NO. 46,47 Platelets rapidly adhere to denuded 
arterial surfaces, 47 but platelet adhesion is diminished 
in regions of high shear stress and decreased transit 
time. 24'48 NO is a potent inhibitor of platelet 
aggregation 23 and platelet adhesion under static 49 and 
flow conditions. 24 Furthermore, platelet activity in 
the vicinity of an arterial injury may influence the 
magnitude of the neointimal response significantly 
through the release of platelet-derived growth factor, 
a potent mitogen and chemotactic factor for VSMCs. 
Platelet-derived growth factor is thought to be 
involved in the regulation of VSMC migration after 
arterial injury. 33,47,5°,51 Thus, diminished platelet ac- 
tivity in a region of high blood flow may result from 
suppression of platelet aggregation caused by in- 
creased local levels of NO or by mechanical interfer- 
ence with platelet adhesion. Treatment with a NO 
synthase inhibitor may have removed the inhibitory 
effects of NO on platelet aggregation, platelet adhe- 
sion, or platelet-derived growth factor release. Para- 
doxically, Sterpetti et al. 33 found that increasing shear 
stress promotes the release of a substance similar to 
platelet-derived growth factor from VSMCs in cul- 
ture, pointing to the need for further elucidation of 
the interactions between blood flow, NO, platelets, 
and other sources of platelet-derived growth factor. 
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